The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

P Verdecchia, C Cavallini, A Spanevello… - European journal of …, 2020 - Elsevier
Abstract Angiotensin converting enzyme-2 (ACE2) receptors mediate the entry into the cell
of three strains of coronavirus: SARS-CoV, NL63 and SARS-CoV-2. ACE2 receptors are …

Predictors of mortality in hospitalized COVID‐19 patients: a systematic review and meta‐analysis

W Tian, W Jiang, J Yao, CJ Nicholson… - Journal of medical …, 2020 - Wiley Online Library
Mortality rates of coronavirus disease‐2019 (COVID‐19) continue to rise across the world.
Information regarding the predictors of mortality in patients with COVID‐19 remains scarce …

[HTML][HTML] ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

CA Devaux, JM Rolain, D Raoult - Journal of Microbiology, Immunology …, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged in
Chinese people in December 2019 and has currently spread worldwide causing the COVID …

[HTML][HTML] Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil

WM de Souza, LF Buss, DS Candido… - Nature human …, 2020 - nature.com
The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and
contextualize epidemiological, demographic and clinical findings for COVID-19 cases during …

Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)

N Mehta, A Kalra, AS Nowacki, S Anjewierden… - JAMA …, 2020 - jamanetwork.com
Importance The role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in the setting of the coronavirus disease 2019 (COVID-19) …

Acute myocardial injury in patients hospitalized with COVID-19 infection: a review

C Bavishi, RO Bonow, V Trivedi, JD Abbott… - Progress in …, 2020 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) is now a global pandemic with millions
affected and millions more at risk for contracting the infection. The COVID-19 virus, SARS …

[HTML][HTML] Evidence regarding vitamin D and risk of COVID-19 and its severity

J Mercola, WB Grant, CL Wagner - Nutrients, 2020 - mdpi.com
Vitamin D deficiency co-exists in patients with COVID-19. At this time, dark skin color,
increased age, the presence of pre-existing illnesses and vitamin D deficiency are features …

COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology

HJ Han, C Nwagwu, O Anyim, C Ekweremadu… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic which has induced …

[HTML][HTML] Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study

C An, H Lim, DW Kim, JH Chang, YJ Choi, SW Kim - Scientific reports, 2020 - nature.com
The rapid spread of COVID-19 has resulted in the shortage of medical resources, which
necessitates accurate prognosis prediction to triage patients effectively. This study used the …

Effect of heart failure on the outcome of COVID-19—a meta analysis and systematic review

E Yonas, I Alwi, R Pranata, I Huang, MA Lim… - The American journal of …, 2021 - Elsevier
Background Several comorbidities have been associated with an increased risk of severity
and mortality in coronavirus disease 2019 (COVID-19), including hypertension, diabetes …